Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00134199
Status:
COMPLETED
Last Update Posted:
2009-08-12
First Post:
2005-08-22
Brief Title:
A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945598 In Obese Subjects
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A 6-Month Randomized Double-Blind Placebo And Positive-Controlled Phase 2b Study To Evaluate The Effect Of Various Doses Of CP-945598 On Weight Loss In Obese Subjects
Status:
COMPLETED
Status Verified Date:
2006-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the effect of 6-month administration of CP-945598 on
weight loss and waist circumference
blood pressure cholesterol glucose
other biochemical variables like insulin leptin ghrelin adiponectin PAI 1 TNF-Î and hsCRP
the relationship between the concentration of the drug on the blood and the above parameters
physical and psychosocial functioning weight related symptoms treatment satisfaction appetitehungersatietycraving and mood anxiety anhedonia and depression
weight loss and waist circumference
blood pressure cholesterol glucose
other biochemical variables like insulin leptin ghrelin adiponectin PAI 1 TNF-Î and hsCRP
the relationship between the concentration of the drug on the blood and the above parameters
physical and psychosocial functioning weight related symptoms treatment satisfaction appetitehungersatietycraving and mood anxiety anhedonia and depression
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None